Axsome Therapeutics Statistics
Total Valuation
AXSM has a market cap or net worth of $7.48 billion. The enterprise value is $7.36 billion.
Important Dates
The last earnings date was Monday, November 3, 2025, before market open.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AXSM has 50.41 million shares outstanding. The number of shares has increased by 3.38% in one year.
| Current Share Class | 50.41M |
| Shares Outstanding | 50.41M |
| Shares Change (YoY) | +3.38% |
| Shares Change (QoQ) | +1.17% |
| Owned by Insiders (%) | 1.13% |
| Owned by Institutions (%) | 76.73% |
| Float | 42.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.98 |
| Forward PS | 8.36 |
| PB Ratio | 101.02 |
| P/TBV Ratio | 381.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 2.96.
| Current Ratio | 1.57 |
| Quick Ratio | 1.45 |
| Debt / Equity | 2.96 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.65 |
Financial Efficiency
Return on equity (ROE) is -275.50% and return on invested capital (ROIC) is -42.17%.
| Return on Equity (ROE) | -275.50% |
| Return on Assets (ROA) | -19.79% |
| Return on Invested Capital (ROIC) | -42.17% |
| Return on Capital Employed (ROCE) | -63.06% |
| Revenue Per Employee | $821,761 |
| Profits Per Employee | -$336,057 |
| Employee Count | 683 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 2.40 |
Taxes
| Income Tax | -875,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.69% in the last 52 weeks. The beta is 0.47, so AXSM's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +47.69% |
| 50-Day Moving Average | 133.62 |
| 200-Day Moving Average | 117.36 |
| Relative Strength Index (RSI) | 59.04 |
| Average Volume (20 Days) | 555,735 |
Short Selling Information
The latest short interest is 3.39 million, so 6.73% of the outstanding shares have been sold short.
| Short Interest | 3.39M |
| Short Previous Month | 3.60M |
| Short % of Shares Out | 6.73% |
| Short % of Float | 7.99% |
| Short Ratio (days to cover) | 6.40 |
Income Statement
In the last 12 months, AXSM had revenue of $561.26 million and -$229.53 million in losses. Loss per share was -$4.66.
| Revenue | 561.26M |
| Gross Profit | 515.60M |
| Operating Income | -194.84M |
| Pretax Income | -230.40M |
| Net Income | -229.53M |
| EBITDA | -187.95M |
| EBIT | -194.84M |
| Loss Per Share | -$4.66 |
Full Income StatementBalance Sheet
The company has $325.27 million in cash and $218.60 million in debt, giving a net cash position of $106.68 million or $2.12 per share.
| Cash & Cash Equivalents | 325.27M |
| Total Debt | 218.60M |
| Net Cash | 106.68M |
| Net Cash Per Share | $2.12 |
| Equity (Book Value) | 73.73M |
| Book Value Per Share | 1.47 |
| Working Capital | 205.05M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$100.95 million and capital expenditures -$439,000, giving a free cash flow of -$101.39 million.
| Operating Cash Flow | -100.95M |
| Capital Expenditures | -439,000 |
| Free Cash Flow | -101.39M |
| FCF Per Share | -$2.01 |
Full Cash Flow StatementMargins
Gross margin is 91.86%, with operating and profit margins of -34.71% and -40.89%.
| Gross Margin | 91.86% |
| Operating Margin | -34.71% |
| Pretax Margin | -41.05% |
| Profit Margin | -40.89% |
| EBITDA Margin | -33.49% |
| EBIT Margin | -34.71% |
| FCF Margin | n/a |
Dividends & Yields
AXSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.38% |
| Shareholder Yield | -3.38% |
| Earnings Yield | -3.08% |
| FCF Yield | -1.36% |
Dividend DetailsAnalyst Forecast
The average price target for AXSM is $176.00, which is 18.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $176.00 |
| Price Target Difference | 18.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 41.65% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AXSM has an Altman Z-Score of 2.8 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.8 |
| Piotroski F-Score | 4 |
